GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,513.00p
   
  • Change Today:
      1.00p
  • 52 Week High: 1,671.00
  • 52 Week Low: 1,264.00
  • Currency: UK Pounds
  • Shares Issued: 4,096.39m
  • Volume: 7,336,765
  • Market Cap: £61,978m
  • RiskGrade: 129

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
2.59% below the market average2.59% below the market average2.59% below the market average2.59% below the market average2.59% below the market average
11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average
1yr Revenue Growth
0.66% below the market average0.66% below the market average0.66% below the market average0.66% below the market average0.66% below the market average
37.93% below the sector average37.93% below the sector average37.93% below the sector average37.93% below the sector average37.93% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
15.68% above the market average15.68% above the market average15.68% above the market average15.68% above the market average15.68% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
1yr DPS Growth
8.52% above the market average8.52% above the market average8.52% above the market average8.52% above the market average8.52% above the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
6.78% below the market average6.78% below the market average6.78% below the market average6.78% below the market average6.78% below the market average
52% below the sector average52% below the sector average52% below the sector average52% below the sector average52% below the sector average
Price Book Ratio
78.19% below the market average78.19% below the market average78.19% below the market average78.19% below the market average78.19% below the market average
31.58% below the sector average31.58% below the sector average31.58% below the sector average31.58% below the sector average31.58% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
51.47% above the market average51.47% above the market average51.47% above the market average51.47% above the market average51.47% above the market average
43.48% above the sector average43.48% above the sector average43.48% above the sector average43.48% above the sector average43.48% above the sector average
Price Chg 3m
1.5% below the market average1.5% below the market average1.5% below the market average1.5% below the market average1.5% below the market average
21.74% above the sector average21.74% above the sector average21.74% above the sector average21.74% above the sector average21.74% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
56.31% above the market average56.31% above the market average56.31% above the market average56.31% above the market average56.31% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Momentum 20
93.76% above the market average93.76% above the market average93.76% above the market average93.76% above the market average93.76% above the market average
90.48% above the sector average90.48% above the sector average90.48% above the sector average90.48% above the sector average90.48% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
17.46% above the market average17.46% above the market average17.46% above the market average17.46% above the market average17.46% above the market average
67.74% above the sector average67.74% above the sector average67.74% above the sector average67.74% above the sector average67.74% above the sector average
ROCE
69.18% above the market average69.18% above the market average69.18% above the market average69.18% above the market average69.18% above the market average
7.69% above the sector average7.69% above the sector average7.69% above the sector average7.69% above the sector average7.69% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
91.27% above the market average91.27% above the market average91.27% above the market average91.27% above the market average91.27% above the market average
91.11% above the sector average91.11% above the sector average91.11% above the sector average91.11% above the sector average91.11% above the sector average
Forecast EPS
79.78% above the market average79.78% above the market average79.78% above the market average79.78% above the market average79.78% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
97.83% above the market average97.83% above the market average97.83% above the market average97.83% above the market average97.83% above the market average
93.55% above the sector average93.55% above the sector average93.55% above the sector average93.55% above the sector average93.55% above the sector average
Operating Profit Loss
97.94% above the market average97.94% above the market average97.94% above the market average97.94% above the market average97.94% above the market average
95.56% above the sector average95.56% above the sector average95.56% above the sector average95.56% above the sector average95.56% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
97.23% above the market average97.23% above the market average97.23% above the market average97.23% above the market average97.23% above the market average
95.45% above the sector average95.45% above the sector average95.45% above the sector average95.45% above the sector average95.45% above the sector average
Cash
96.84% above the market average96.84% above the market average96.84% above the market average96.84% above the market average96.84% above the market average
95.45% above the sector average95.45% above the sector average95.45% above the sector average95.45% above the sector average95.45% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
73.98% above the market average73.98% above the market average73.98% above the market average73.98% above the market average73.98% above the market average
83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average
Buys 1y
99.34% above the market average99.34% above the market average99.34% above the market average99.34% above the market average99.34% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
92.05% below the market average92.05% below the market average92.05% below the market average92.05% below the market average92.05% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Brokers Percent Neutral
76.54% above the market average76.54% above the market average76.54% above the market average76.54% above the market average76.54% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,513.00p
Change Today 1.00p
% Change 0.07 %
52 Week High 1,671.00
52 Week Low 1,264.00
Volume 7,336,765
Shares Issued 4,096.39m
Market Cap £61,978m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
55.52% below the market average55.52% below the market average55.52% below the market average55.52% below the market average55.52% below the market average
39.13% above the sector average39.13% above the sector average39.13% above the sector average39.13% above the sector average39.13% above the sector average
Price Trend
34.93% above the market average34.93% above the market average34.93% above the market average34.93% above the market average34.93% above the market average
52.17% above the sector average52.17% above the sector average52.17% above the sector average52.17% above the sector average52.17% above the sector average
Income
69.86% above the market average69.86% above the market average69.86% above the market average69.86% above the market average69.86% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
34.75% below the market average34.75% below the market average34.75% below the market average34.75% below the market average34.75% below the market average
40% below the sector average40% below the sector average40% below the sector average40% below the sector average40% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 14
Sell 3
Strong Sell 1
Total 24
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 15-May-25 20-Feb-25
Paid 10-Jul-25 10-Apr-25
Amount 16.00p 16.00p

Trades for 06-Jun-2025

Time Volume / Share Price
16:13 0 @ 1,511.00p
16:13 0 @ 1,511.00p
15:24 0 @ 1,514.50p
16:47 54,842 @ 1,510.99p
14:53 0 @ 1,513.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page